Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Optimal treatment of prostate cancer in changing times

State-of-the-art management of metastatic hormone-sensitive prostate cancer (mHSPC)

Date

20 Nov 2020

Session

Optimal treatment of prostate cancer in changing times

Topics

Tumour Site

Prostate Cancer

Presenters

Karim Fizazi

Authors

K. Fizazi

Author affiliations

Cancer Medicine Department, Institut Gustave Roussy, 94805 - Villejuif/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

20 Nov 2020

Metastatic castration-resistant prostate (mCRPC) cancer updates

Presenter: Silke Gillessen

Session: Optimal treatment of prostate cancer in changing times

Resources:

Slides

Webcast

20 Nov 2020

Ethnic differences (pharmacogenomic differences in Asian patients) in the management of metastatic prostate cancer

Presenter: Ming Chun Poon

Session: Optimal treatment of prostate cancer in changing times

Resources:

Slides

Webcast

20 Nov 2020

LIVE Q&A

Presenter: Ravindran Kanesvaran

Session: Optimal treatment of prostate cancer in changing times

Resources:

Webcast